Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Trading Performance

Williams %R

Score

0.75

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 18 18.6 0.67% 1.50% 5.2% -4.3% 27.9%
SHORT 18 23.5 0.72% 2.60% 5.2% -9.3% 20.7%

Summary

Technical Analysis

Opthea (OPT.AX)


Indicator:

WILLIAMS %R


Last Signal:

BULLISH


Trading: BUY @ $0.86
Signal Strength: STRONG
Recommendation:

Indicator is best used in conjunction with additional indicators as it has the ability to highlight potential overbought or oversold levels. This indicator utilizes upper and lower bands to visually represent price extremes associated with the bands. Additional value can be added to the trading strategy by accessing divergences between price and volume.


Opthea (ASX:OPT) is currently Oversold highlighting the potential for a short term trend reversal in the upward direction.



Developed by Larry Williams, Williams %R is a momentum indicator that is the inverse of the Fast Stochastic Oscillator. Also referred to as %R Williams %R reflects the level of the close relative to the highest high for the look-back period.

Calculation: Williams %R:
1) %R = (Highest High - Close)/(Highest High - Lowest Low) * -100;
2) Lowest Low = lowest low for the look-back period Highest High = highest high for the look-back period %R is multiplied by -100 correct the inversion and move the decimal;


PROFILE: Opthea (OPT.AX)


Stock Exchange: ASX
Company: Opthea
Ticker Codes: | OPT.AX | ASX:OPT |

About Opthea (ASX:OPT):

Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.

Top 10:

Williams %R

Download
Company Close Change(%) Volume Value Signal
URF Us Masters Residential Property Fund 0.89 6 46,089 80 BULLISH
KAR Karoon Gas Australia 1.23 3.8 1,326,249 95.8 BULLISH
ELX Ellex Medical Lasers 0.61 3.4 188,404 100 BULLISH
IRE Iress Market Technology 13.79 3.1 653,795 91.4 BULLISH
IPL Incitec Pivot 3.42 3 8,443,078 100 BULLISH
BPT Beach Petroleum 2.04 2.3 5,556,679 98.3 BULLISH
PRT Prime Television 0.24 2.2 112,542 93.3 BULLISH
PWH PWR 4.15 2.2 156,904 88.8 BULLISH
HLO Helloworld 4.98 2 43,873 93.3 BULLISH
ASB Austal 4.11 2 3,707,539 86.6 BULLISH